Tag
#pharmaceuticals
3 studies
Weight Loss Jul 22, 2026
RCT · The lancet. Diabetes & endocrinology
New Dual-Action Drug Outperforms Semaglutide in Diabetes Trial
A new combination therapy called CagriSema shows superior blood sugar control compared to semaglutide alone in a major phase 3 clinical trial.
Read Analysis Weight Loss Jul 22, 2026
RCT · Nature medicine
An Oral Pill Helps Maintain Weight Loss After Injectables
A new clinical trial shows a daily oral medication can help prevent weight regain after stopping weekly injectables.
Read Analysis Weight Loss May 27, 2026
RCT · Lancet (London, England)
New Daily Pill Shows Promise for Diabetes and Weight
A new phase 3 trial reveals that a daily oral pill called orforglipron could provide a highly effective, injection-free alternative for managing type 2 diabetes and body weight.
Read Analysis